HPAPIs Angled Paper Icon
High-potency drugs derived from natural products command a large and growing market share in the pharmaceutical industry. In 2019, revenues at contract
development and manufacturing organizations (CDMOs) related to high-potency active pharmaceutical ingredients (HPAPIs) manufacturing were an estimated $10 billion.
 

Download this white paper to:

  • Learn how the expertise of CDMOs in HPAPI manufacturing is becoming increasingly relevant
  • Why clients come to CDMOs at various stages of process design and more!
 
 





 
User-added image



With over 50 years of experience, we are a forward-thinking,
North American CDMO specializing in clinical-to-commercial scale production of high-quality regulated APIs and Intermediates.



 

Contact Us

Toll Free: +1 (866) 883-2872

Phone: +1 (902) 566-9116

Fax: +1 (902) 628-2045

11 Aviation Avenue,
Charlottetown, PE, C1E 0A1
Canada

 


© Copyright BIOVECTRA 2022.
All Rights Reserved.
 
 
 
 
Privacy Policy   
Terms of Service